Daiichi, J&J Unit Continue Fight For Levaquin Patent
After a series of courtroom victories over anti-infective drug Levaquin, Japanese drug maker Daiichi Pharmaceutical Co. and a Johnson & Johnson subsidiary have filed a lawsuit to fight another effort to...To view the full article, register now.
Already a subscriber? Click here to view full article